QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
NASDAQ:MDGL

Madrigal Pharmaceuticals (MDGL) Earnings Date, Estimates & Call Transcripts

$269.04
-9.37 (-3.37%)
(As of 06/1/2023 ET)
Compare
Today's Range
$266.12
▼
$283.43
50-Day Range
$234.08
▼
$312.00
52-Week Range
$57.21
▼
$322.67
Volume
332,462 shs
Average Volume
385,686 shs
Market Capitalization
$4.92 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$312.36
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Aug. 3Estimated
Actual EPS
(May. 9)
-$4.23 Beat By $0.55
Consensus EPS
(May. 9)
-$4.78
Last Year's Q2 EPS
(5/9/2022)
-$3.36
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

MDGL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MDGL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Madrigal Pharmaceuticals Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20234($4.72)($3.04)($3.95)
Q2 20234($4.71)($3.61)($4.13)
Q3 20234($4.71)($3.56)($4.15)
Q4 20234($4.76)($0.88)($3.41)
FY 202316($18.90)($11.09)($15.64)

MDGL Earnings Date and Information

Madrigal Pharmaceuticals last released its earnings results on May 9th, 2023. The biopharmaceutical company reported ($4.23) earnings per share for the quarter, topping analysts' consensus estimates of ($4.78) by $0.55. Madrigal Pharmaceuticals has generated ($18.10) earnings per share over the last year (($18.10) diluted earnings per share). Earnings for Madrigal Pharmaceuticals are expected to grow in the coming year, from ($18.65) to ($8.31) per share. Madrigal Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 3rd, 2023 based off prior year's report dates.

Madrigal Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/3/2023
(Estimated)		        
5/9/2023Q1 2023($4.78)($4.23)+$0.55($4.23)
2/23/2023Q4 2022($4.61)($4.98)($0.37)($4.98)
11/3/2022Q3 2022($4.05)($4.75)($0.70)($4.75)
8/4/2022Q2 2022($3.76)($4.14)($0.38)($4.14)
5/9/2022Q1 2022($3.75)($3.36)+$0.39($3.36)    
2/24/2022Q4 2021($3.92)($3.78)+$0.14($3.78)    
11/4/20219/30/2021($3.87)($3.79)+$0.08($3.79)
8/5/20216/30/2021($3.58)($3.72)($0.14)($3.72)
5/6/20213/31/2021($3.85)($3.32)+$0.53($3.32)  
2/25/202112/31/2020($3.98)($3.82)+$0.16($3.82)
11/5/20209/30/2020($3.37)($3.75)($0.38)($3.75)  
8/6/20206/30/2020($2.43)($3.18)($0.75)($3.18)
5/7/20203/31/2020($1.94)($2.34)($0.40)($2.34)
2/26/2020Q4 2019($1.67)($1.80)($0.13)($1.80)
11/6/2019Q3($1.42)($1.39)+$0.03($1.39)
8/7/2019Q2 2019($1.22)($1.28)($0.06)($1.28)
5/8/20193/31/2019($1.00)($0.98)+$0.02($0.98)
2/27/2019Q4 2018($0.75)($0.75)($0.75)
11/6/20189/30/2018($0.53)($0.56)($0.03)($0.56)
8/7/2018Q2 2018($0.6260)($0.45)+$0.1760($0.45)
5/8/2018Q1 2018($0.7770)($0.45)+$0.3270($0.45)
3/13/2018Q4 2017($0.70)($0.67)+$0.03($0.67)
11/9/2017Q3 2017($0.7870)($0.68)+$0.1070($0.68)
8/10/2017Q2 2017($0.60)($0.69)($0.09)($0.69)
5/11/2017Q1 2017($0.87)($0.50)+$0.37($0.50)
4/3/2017Q4 2016($1.39)($0.67)+$0.72($0.67)
11/14/2016Q3 2016($1.34)($1.34)($1.34)
7/20/2016Q2 2016($0.70)($0.70)($0.70)
5/10/2016Q1 2016($1.75)($1.75)($1.75)
3/15/2016Q4($0.18)($0.08)+$0.10($0.08)
11/5/2015Q3($0.16)($0.13)+$0.03($0.13)
8/6/2015Q215($0.18)($0.15)+$0.03($0.15)  
5/7/2015Q115($0.19)($0.19)($0.19)  
3/12/2015Q4($0.19)($0.19)($0.19)$0.13 million  
11/6/2014Q3($0.23)($0.19)+$0.04($0.19)$0.13 million  
8/6/2014Q2($0.25)($0.24)+$0.01($0.24)$480.00 million  
5/8/2014Q1($0.28)($0.28)($0.28)  
3/11/2014Q4 2013($10.84)($10.84)($10.84)$0.37 million  
11/4/2013Q3 2013($11.89)($11.54)+$0.35($11.54)  
8/1/2013Q2 2013($10.49)($11.54)($1.05)($11.54)  
4/30/2013Q1 2013($9.79)($10.49)($0.70)($10.49)
3/14/2013Q4 2012($9.44)($10.14)($0.70)($10.14)
11/6/2012Q312($0.24)($0.25)($0.01)$1.60 million
8/2/2012Q2 2012($9.44)($8.88)+$0.56($8.88)
5/3/2012Q1 2012($8.74)($9.44)($0.70)($9.44)
2/22/2012Q4 2011($9.44)($7.59)+$1.85($7.59)
11/3/2011Q3 2011($9.79)($10.56)($0.77)($10.56)
8/4/2011Q2 2011($6.64)($10.35)($3.71)($10.35)
5/5/2011Q1 2011($9.44)($9.48)($0.04)($9.48)
3/11/2011Q4 2010($5.24)($7.48)($2.24)($7.48)
11/4/2010Q3 2010($7.69)($8.88)($1.19)($8.88)
8/9/2010Q2 2010($8.04)($7.69)+$0.35($7.69)
5/4/2010Q1 2010($7.34)($8.39)($1.05)($8.39)
3/11/2010Q4 2009($9.09)($7.24)+$1.85($7.24)
11/4/2009Q3 2009$61.19$121.82+$60.63$121.82
8/4/2009Q2 2009($11.89)($8.78)+$3.11($8.78)
5/7/2009Q1 2009($18.88)($23.01)($4.13)($21.75)
3/26/2009Q4 2008($28.32)($26.89)+$1.43($26.89)
11/13/2008Q3 2008($22.38)($27.27)($4.89)($27.27)
8/7/2008Q2 2008($19.93)($23.53)($3.60)($23.53)
5/14/2008Q1 2008($19.23)($18.29)+$0.94($18.29)
3/20/2008Q4 2007($18.18)($16.12)+$2.06($16.12)












Madrigal Pharmaceuticals Earnings - Frequently Asked Questions

When is Madrigal Pharmaceuticals's earnings date?

Madrigal Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 3rd, 2023 based off last year's report dates. Learn more on MDGL's earnings history.

Did Madrigal Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Madrigal Pharmaceuticals (NASDAQ:MDGL) reported ($4.23) earnings per share (EPS) to beat the analysts' consensus estimate of ($4.78) by $0.55. Learn more on analysts' earnings estimate vs. MDGL's actual earnings.

How much profit does Madrigal Pharmaceuticals generate each year?

Madrigal Pharmaceuticals (NASDAQ:MDGL) has a recorded net income of -$295.35 million. MDGL has generated -$18.10 earnings per share over the last four quarters.

What is Madrigal Pharmaceuticals's EPS forecast for next year?

Madrigal Pharmaceuticals's earnings are expected to grow from ($18.65) per share to ($8.31) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:MDGL) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -